Overview

  • Product name(R)-CPPene (SDZ EAA 494)
  • Description
    Potent competitive NMDA antagonist
  • Alternative names
    • D-CPP ene
    • Midafotel
    • SDZ EAA 494
  • Biological descriptionPotent competitive NMDA antagonist. Centrally active following systemic administration.

    Also available in simple stock solutions (ab146715) - add 1 ml of water to get an exact, ready-to-use concentration.
  • Purity> 98%

Properties

    References for (R)-CPPene (SDZ EAA 494) (ab120232)

    This product has been referenced in:
    • Park CK  et al. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat. Neurosci Lett 147:41-4 (1992). Read more (PubMed: 1480321) »
    • Lowe DA  et al. D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801. Neurosci Lett 113:315-21 (1990). Read more (PubMed: 2166255) »
    • Patel S  et al. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Epilepsy Res 7:3-10 (0). Read more (PubMed: 2292244) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120232.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"